this is big news for biota - a massive market with a large part of the pop which can afford the product.
IMO demand from china alone could easily soak up all of gsks 190,000 doses/yr.
- Forums
- ASX - By Stock
- relenza approved for sale in china
this is big news for biota - a massive market with a large part...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online